CSE1L | CSE1 chromosome segregation 1-like (yeast) | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
CSTA | Cystatin A (stefin A) | Cancer-related genes Disease related genes Plasma proteins
| | | | | Tissue enhanced |
CSTB | Cystatin B (stefin B) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Transporters
| | | | | Group enriched |
CTNNB1 | Catenin (cadherin-associated protein), beta 1, 88kDa | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
CYB5R3 | Cytochrome b5 reductase 3 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
DAXX | Death-domain associated protein | Cancer-related genes
| | | | | Expressed in all |
DDB2 | Damage-specific DNA binding protein 2, 48kDa | Cancer-related genes Disease related genes
| | | | | Expressed in all |
DEK | DEK oncogene | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
E2F1 | E2F transcription factor 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
EBAG9 | Estrogen receptor binding site associated, antigen, 9 | Cancer-related genes Predicted secreted proteins
| | | | | Expressed in all |
EFNB2 | Ephrin-B2 | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Mixed |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EGR1 | Early growth response 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
EI24 | Etoposide induced 2.4 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
EIF4E | Eukaryotic translation initiation factor 4E | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
EIF4EBP1 | Eukaryotic translation initiation factor 4E binding protein 1 | Cancer-related genes
| | | | | Expressed in all |
ENG | Endoglin | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ENO1 | Enolase 1, (alpha) | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
ERBB2 | V-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ERCC1 | Excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence) | Cancer-related genes Disease related genes
| | | | | Expressed in all |
ERCC2 | Excision repair cross-complementing rodent repair deficiency, complementation group 2 | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
ERCC4 | Excision repair cross-complementing rodent repair deficiency, complementation group 4 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
ERCC5 | Excision repair cross-complementing rodent repair deficiency, complementation group 5 | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
ETHE1 | Ethylmalonic encephalopathy 1 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | | | Expressed in all |
ETV4 | Ets variant 4 | Cancer-related genes Transcription factors
| | | | | Mixed |
EZH2 | Enhancer of zeste homolog 2 (Drosophila) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Mixed |
EZR | Ezrin | Cancer-related genes Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
F13A1 | Coagulation factor XIII, A1 polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
FABP2 | Fatty acid binding protein 2, intestinal | Cancer-related genes Plasma proteins
| | | | | Group enriched |
FABP4 | Fatty acid binding protein 4, adipocyte | Cancer-related genes Plasma proteins
| | | | | Tissue enriched |
FABP5 | Fatty acid binding protein 5 (psoriasis-associated) | Cancer-related genes Plasma proteins Transporters
| | | | | Expressed in all |
FADD | Fas (TNFRSF6)-associated via death domain | Cancer-related genes Disease related genes
| | | | | Expressed in all |
FASN | Fatty acid synthase | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
FEN1 | Flap structure-specific endonuclease 1 | Cancer-related genes Plasma proteins
| | | | | Expressed in all |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets RAS pathway related proteins
| | | | | Group enriched |
FKBP5 | FK506 binding protein 5 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
FKBP8 | FK506 binding protein 8, 38kDa | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
FOXO3 | Forkhead box O3 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
FSCN1 | Fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) | Cancer-related genes Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
G6PD | Glucose-6-phosphate dehydrogenase | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
GATA3 | GATA binding protein 3 | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
GCLM | Glutamate-cysteine ligase, modifier subunit | Cancer-related genes
| | | | | Expressed in all |
GLO1 | Glyoxalase I | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
GMNN | Geminin, DNA replication inhibitor | Cancer-related genes
| | | | | Expressed in all |
GPX1 | Glutathione peroxidase 1 | Cancer-related genes Enzymes Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
GSN | Gelsolin | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
GSR | Glutathione reductase | Cancer-related genes Enzymes FDA approved drug targets Mitochondrial proteins Plasma proteins
| | | | | Expressed in all |
GSTM3 | Glutathione S-transferase mu 3 (brain) | Cancer-related genes Enzymes
| | | | | Expressed in all |
GSTP1 | Glutathione S-transferase pi 1 | Cancer-related genes Enzymes Plasma proteins
| | | | | Expressed in all |
HDAC2 | Histone deacetylase 2 | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |